Avalo Therapeutics, Inc. - COM NEW (AVTX)

Historical Portfolio Holders from Q4 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
771K
Holdings value Q2 2024
$9.62M
Value change Q2 2024
+$8.43M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
21
Number of buys Q2 2024
11
Number of sells Q2 2024
-8
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 771K $9.62M +$8.43M $12.47 21
2024 Q1 87.2K $1.9M +$1.4M $21.75 17
2023 Q4 23K $209K +$209K $9.00 12